Association of Body Mass Index-Adjusted Body Cell Mass and Lean Body Mass with Metabolic Syndrome and Insulin Resistance in Middle-Aged and Older Adults: A Cross-Sectional Study.
{"title":"Association of Body Mass Index-Adjusted Body Cell Mass and Lean Body Mass with Metabolic Syndrome and Insulin Resistance in Middle-Aged and Older Adults: A Cross-Sectional Study.","authors":"Sinyoung Cho, Joongyub Lee, Jae Moon Yun, Hyuktae Kwon","doi":"10.7570/jomes25022","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>This study was conducted to examine the association of body mass index (BMI)-adjusted body cell mass (BCM; BCM<sub>bmi</sub>) and lean body mass (LBM; LBM<sub>bmi</sub>) with metabolic markers, metabolic syndrome (MetS), and insulin resistance (IR) in middle-aged and older Korean adults.</p><p><strong>Methods: </strong>This cross-sectional study included 9,522 adults (4,456 males and 5,066 females) without a history of myocardial infarction, stroke, or cancer from the Ansan-Ansung Study of the Korean Genome and Epidemiology Study. Multivariable linear regression was conducted to evaluate the association of BCM<sub>bmi</sub> and LBM<sub>bmi</sub> with metabolic markers. Logistic regression analyses were conducted to evaluate the association of BCM<sub>bmi</sub> and LBM<sub>bmi</sub> with metabolic abnormalities, including MetS and IR. MetS diagnosis followed National Cholesterol Education Program Adult Treatment Panel III criteria, and IR was assessed using the homeostatic model assessment index of insulin resistance (HOMA-IR).</p><p><strong>Results: </strong>BCM<sub>bmi</sub> and LBM<sub>bmi</sub> were negatively associated with fasting glucose, fasting insulin, HOMA-IR, triglycerides, alanine/aspartate aminotransferase, uric acid, and high-sensitivity C-reactive protein, while they were positively associated with high-density lipoprotein cholesterol. The magnitudes of regression coefficients were generally greater for BCM<sub>bmi</sub> than for LBM<sub>bmi</sub>. A total of 3,590 (37.7%) and 3,490 (36.7%) participants were categorized as having MetS and IR. Compared to the lowest tertile of BCM<sub>bmi</sub>, the highest tertiles were associated with lower odds ratio of MetS (males: 0.36 [95% confidence interval, CI, 0.30 to 0.42], females: 0.23 [95% CI, 0.20 to 0.27]) and IR (males: 0.34 [95% CI, 0.30 to 0.40], females: 0.33 [95% CI, 0.28 to 0.38]), all with significant trends (<i>P</i> for trend <0.001).</p><p><strong>Conclusion: </strong>The results suggest that BCM<sub>bmi</sub> is independently associated with metabolic markers and demonstrate comparable predictive power to LBM<sub>bmi</sub> for MetS and IR, particularly in males.</p>","PeriodicalId":45386,"journal":{"name":"Journal of Obesity & Metabolic Syndrome","volume":" ","pages":"61-71"},"PeriodicalIF":12.7000,"publicationDate":"2026-01-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12884597/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Obesity & Metabolic Syndrome","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.7570/jomes25022","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2026/1/16 0:00:00","PubModel":"Epub","JCR":"Q1","JCRName":"ENDOCRINOLOGY & METABOLISM","Score":null,"Total":0}
引用次数: 0
Abstract
Background: This study was conducted to examine the association of body mass index (BMI)-adjusted body cell mass (BCM; BCMbmi) and lean body mass (LBM; LBMbmi) with metabolic markers, metabolic syndrome (MetS), and insulin resistance (IR) in middle-aged and older Korean adults.
Methods: This cross-sectional study included 9,522 adults (4,456 males and 5,066 females) without a history of myocardial infarction, stroke, or cancer from the Ansan-Ansung Study of the Korean Genome and Epidemiology Study. Multivariable linear regression was conducted to evaluate the association of BCMbmi and LBMbmi with metabolic markers. Logistic regression analyses were conducted to evaluate the association of BCMbmi and LBMbmi with metabolic abnormalities, including MetS and IR. MetS diagnosis followed National Cholesterol Education Program Adult Treatment Panel III criteria, and IR was assessed using the homeostatic model assessment index of insulin resistance (HOMA-IR).
Results: BCMbmi and LBMbmi were negatively associated with fasting glucose, fasting insulin, HOMA-IR, triglycerides, alanine/aspartate aminotransferase, uric acid, and high-sensitivity C-reactive protein, while they were positively associated with high-density lipoprotein cholesterol. The magnitudes of regression coefficients were generally greater for BCMbmi than for LBMbmi. A total of 3,590 (37.7%) and 3,490 (36.7%) participants were categorized as having MetS and IR. Compared to the lowest tertile of BCMbmi, the highest tertiles were associated with lower odds ratio of MetS (males: 0.36 [95% confidence interval, CI, 0.30 to 0.42], females: 0.23 [95% CI, 0.20 to 0.27]) and IR (males: 0.34 [95% CI, 0.30 to 0.40], females: 0.33 [95% CI, 0.28 to 0.38]), all with significant trends (P for trend <0.001).
Conclusion: The results suggest that BCMbmi is independently associated with metabolic markers and demonstrate comparable predictive power to LBMbmi for MetS and IR, particularly in males.
期刊介绍:
The journal was launched in 1992 and diverse studies on obesity have been published under the title of Journal of Korean Society for the Study of Obesity until 2004. Since 2017, volume 26, the title is now the Journal of Obesity & Metabolic Syndrome (pISSN 2508-6235, eISSN 2508-7576). The journal is published quarterly on March 30th, June 30th, September 30th and December 30th. The official title of the journal is now "Journal of Obesity & Metabolic Syndrome" and the abbreviated title is "J Obes Metab Syndr". Index words from medical subject headings (MeSH) list of Index Medicus are included in each article to facilitate article search. Some or all of the articles of this journal are included in the index of PubMed, PubMed Central, Scopus, Embase, DOAJ, Ebsco, KCI, KoreaMed, KoMCI, Science Central, Crossref Metadata Search, Google Scholar, and Emerging Sources Citation Index (ESCI).